1. Home
  2. TALKW vs GRMLW Comparison

TALKW vs GRMLW Comparison

Compare TALKW & GRMLW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Talkspace Inc. Warrant

TALKW

Talkspace Inc. Warrant

N/A

Current Price

$0.00

Market Cap

0.0

Sector

Health Care

ML Signal

N/A

GRMLW

Greenland Mines Ltd Warrant

N/A

Current Price

$0.20

Market Cap

0.0

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TALKW
GRMLW
Founded
2012
N/A
Country
United States
United States
Employees
598
5
Industry
Medical/Nursing Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
N/A
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
TALKW
GRMLW
Price
$0.00
$0.20
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
63.8K
10.3K
Earning Date
02-20-2025
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$181,291,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
31.50
N/A
52 Week Low
$0.00
$0.10
52 Week High
$0.15
$0.37

Technical Indicators

Market Signals
Indicator
TALKW
GRMLW
Relative Strength Index (RSI) 43.76 55.77
Support Level N/A $0.12
Resistance Level $0.01 $0.23
Average True Range (ATR) 0.00 0.05
MACD 0.00 -0.00
Stochastic Oscillator 86.96 19.89

Price Performance

Historical Comparison
TALKW
GRMLW

About TALKW Talkspace Inc. Warrant

Talkspace Inc is a virtual behavioral healthcare company offering its members convenient and affordable access to a fully-credentialed network of qualified providers across a wide and growing spectrum of care through virtual psychotherapy and psychiatry. It is a single destination for comprehensive mental health care, including therapy for individuals, couples, and teens, as well as psychiatric treatment and medication management (18+), and self-guided tools and resources. The company's customers include Health insurance plans from commercial and government institutions, and employee assistance programs, Direct-to-Enterprise, and Individual subscribers. The company operates as a single segment.

About GRMLW Greenland Mines Ltd Warrant

Greenland Mines Ltd develops essential medicines for the treatment of chronic diseases - cancer, cardiovascular, and neurodegenerative disorders. The Company operates as a single reporting segment focused on developing essential medicines for these chronic diseases. The Company has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and proprietary patented technologies involving melanocortin receptor-binding molecules and a gene therapy platform that introduces a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases.

Share on Social Networks: